Document Detail


Cardiovascular effects of AR-L115 BS in conscious dogs with and without chronic congestive heart failure.
MedLine Citation:
PMID:  6177937     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AR-L115 BS is a phenyl-imidazo-pyridine derivative that combines positive inotropic and vasodilator properties. To analyze the mechanisms of action of AR-L115 in the presence or absence of heart failure, we administered it intravenously to conscious dogs (seven normals and eight with a volume-overload heart failure). In normals, at a plasma level around 1,000 ng/ml, AR-L115 BS increased left ventricular (LV) peak (+) dP/dt (+48%; p less than 0.02) and heart rate (+29 beats/min; p less than 0.05) without altering significantly cardiac filling pressures or cardiac output. The mean aortic pressure and the systemic vascular resistances (-20%; p less than 0.02) were reduced, but plasma renin activity (PRA) was unchanged. In heart failure, the same plasma level increased peak (+) dP/dt by 36% (p less than 0.01), but heart rate stayed unchanged. Mean aortic pressure, systemic vascular resistances (-20%; p less than 0.01), and LV end-diastolic pressure (-9.1 mm Hg; p less than 0.01) all dropped significantly, while cardiac output increased slightly; PRA did not rise significantly. After beta-blockade, the increases in peak (+) dP/dt and the changes in systemic vascular resistances were markedly reduced. In conclusion, AR-L115 BS has strong positive inotropic and vasodilator effects, both of which are partially dependent on the level of the sympathetic tone in the intact animal. These combined properties improve hemodynamics in heart failure; this improvement is already significant at relatively low plasma levels, at which deleterious changes in heart rate or PRA are absent.
Authors:
H Pouleur; M F Rousseau; H van Mechelen; L Roncoroni; A Ries; A A Charlier
Related Documents :
9523817 - Influence of acidosis on cardiotonic effects of milrinone.
22872687 - Role of 11βhsd type 2 enzyme activity in essential hypertension and children with chro...
22420987 - Energy requirement for alkali assisted microwave and high pressure reactor pretreatment...
22890227 - Blepharo-tensiometer: new eyelid pressure measurement system using tactile pressure sen...
1939377 - Graded postischemic reoxygenation ameliorates inhibition of cerebral cortical protein s...
21839757 - Differential contributions of theobromine and caffeine on mood, psychomotor performance...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  4     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:    1982 May-Jun
Date Detail:
Created Date:  1982-08-26     Completed Date:  1982-08-26     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  409-18     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / pharmacology
Animals
Calcium / pharmacology
Cardiotonic Agents / pharmacology*
Dogs
Heart / anatomy & histology,  drug effects
Heart Failure / physiopathology*
Hemodynamics / drug effects*
Imidazoles / pharmacology*
Myocardial Contraction / drug effects
Renin / blood
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Cardiotonic Agents; 0/Imidazoles; 73384-60-8/sulmazole; 7440-70-2/Calcium; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiovascular functions of brain serotonergic neurons in the rabbit as analysed from the acute and ...
Next Document:  Cardiovascular effects of tiapamil (Ro 11-1781), a new calcium-entry blocker.